| 000 | 01411 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515063115.0 | ||
| 264 | 0 | _c20070612 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1016/j.bbrc.2007.03.115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcCabe, Cillian | |
| 245 | 0 | 0 |
_aBeta cell cytoprotection using lentiviral vector-based iNOS-specific shRNA delivery. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cMay 2007 |
||
| 300 |
_a75-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCytoprotection _xdrug effects |
| 650 | 0 | 4 |
_aGene Silencing _xphysiology |
| 650 | 0 | 4 |
_aGenetic Vectors _xgenetics |
| 650 | 0 | 4 |
_aInsulin-Secreting Cells _xcytology |
| 650 | 0 | 4 |
_aInterleukin-1beta _xadministration & dosage |
| 650 | 0 | 4 |
_aLentivirus _xgenetics |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xadministration & dosage |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTransfection _xmethods |
| 700 | 1 | _aO'Brien, Timothy | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 357 _gno. 1 _gp. 75-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2007.03.115 _zAvailable from publisher's website |
| 999 |
_c16959895 _d16959895 |
||